Alizyme PLC (AZM.L) Release: Unaudited Preliminary Results For The Year Ended 31 December 2008
3/23/2009 2:54:26 PM
More...
|
Alizyme PLC (AZM.L) Announces Headline Results from Its European Phase 3 Clinical Trial
7/24/2008 1:59:41 PM
More...
|
Alizyme PLC (AZM.L) Commencement of Phase 2 Study in the U.S.
5/20/2008 12:51:41 PM
More...
|
Prometheus Laboratories Inc. Licenses COLAL-PRED(R) From Alizyme PLC (AZM.L)
11/29/2007 8:05:51 AM
More...
|
Alizyme PLC (AZM.L) Release: Preliminary Results And Webcast Notification
2/14/2007 1:14:44 PM
More...
|
UK's Alizyme PLC (AZM.L) Shares Boosted By Phase 2 Mucositis Drug Data
3/2/2006 10:32:38 AM
More...
|
Alizyme PLC (AZM.L) Successful Phase IIb Cetilistat Trial In Obese Diabetics
12/13/2005 3:06:43 PM
More...
|
Alizyme PLC (AZM.L) Completes Recruitment For Mucositis Trials, Sees Results Feb 2006
11/22/2005 2:21:00 PM
More...
|
Alizyme PLC (AZM.L) Obtains Approval For Phase III Clinical Trial Of COLAL-PRED® For The Treatment Of Ulcerative Colitis
10/19/2005 5:13:01 PM
More...
|
Alizyme PLC (AZM.L) The UK Based Speciality Biopharmaceutical Development Company, Today Announces That It Proposes To Raise £32.8 Million
10/19/2005 5:11:08 PM
More...
|
|